Table 1.
VRT (n=28) | ART (n=15) | P value | |
---|---|---|---|
Median Age (years) | 30 (27–32) | 34 (32–36) | 0.0003 |
Histology: | 0.53 | ||
Adenocarcinoma | 13 (46.6%) | 9 (60%) | |
Squamous cell carcinoma | 15 (53.6%) | 6 (40%) | |
Residual Disease in Specimen | 14 (50%) | 9 (60%) | 0.74 |
Lymph vascular space invasion | 10 (35.7%) | 7 (46.7%) | 0.53 |
Median lymph nodes obtained | 31 (21–42) | 24 (18–30) | 0.14 |
Conversion to hysterectomy | 2 (7.1%) | 2 (13.3%) | 0.6 |
Median estimated blood loss (mL) | 100 (56–200) | 300 (100–350) | 0.001 |
Median operating time (minutes) | 363 (310–398) | 319 (298–338) | 0.01 |
Complications (# patients) | 12 | 2 | 0.09 |
Median hospital stay (days) | 3 (3–5) | 4 (3–5) | 0.35 |
Median follow up interval (months) | 24.9 (12.7–31.2) | 11.6 (2.7–18.2) | 0.006 |
Radiation or chemoradiation | 5 (17.9%) | 7 (46.7%) | 0.07 |
Results reported as n (%) or n (25%ile – 75%ile). VRT, vaginal radical trachelectomy; ART, abdominal radical trachelectomy.